Cryo-Cell International, Inc. Quarterly report [Sections 13 or 15(d)]

Notes Payable (Tables)

9 Months Ended

Aug. 31, 2025

As of August 31, 2025 and November 30, 2024, the note payable obligation was as follows:


	August 31, 2025			November 30, 2024
Note payable - Susser	$	8,518,465		$	8,628,700
Unamortized debt issuance costs - Susser		(132,510	)		(148,167	)
Net note payable	$	8,385,955		$	8,480,533
Current portion of note payable	$	179,187		$	170,488
Long-term note payable, net of debt issuance costs		8,206,768			8,310,045
Total	$	8,385,955		$	8,480,533

Interest expense on the note payable for the three and nine months ended August 31, 2025 and 2024 was as follows:


	For the three months ended		For the nine months ended
	August 31, 2025		August 31, 2025
Interest expense on notes payable - Susser	$	244,006	$	706,161
Debt issuance costs - Susser		5,192		15,657
Total interest expense	$	249,198	$	721,818


	For the three months ended		For the nine months ended
	August 31, 2024		August 31, 2024
Interest expense on notes payable - Susser	$	254,758	$	301,924
Debt issuance costs - Susser		5,297		5,297
Total interest expense	$	260,055	$	307,221